Regenerative medicine is extensively interested in developing cell therapies using
mesenchymal stem cells (MSCs), with applications to several aging-associated diseases …

The key hallmark of stem cells is their ability to self-renew while keeping a differentiation
potential. Intrinsic and extrinsic cell factors may contribute to a decline in these stem cell …

Various source-derived mesenchymal stem cells (MSCs) have been considered for cell
therapeutics in incurable diseases. To characterize MSCs from different sources, we …

The use of human mesenchymal stem cells (hMSCs) in cell-based therapy has attracted
extensive interest in the field of regenerative medicine, and it shows applications to …

Mesenchymal stem/stromal cells (MSC) show widespread application for a variety of clinical
conditions; therefore, their use necessitates continuous monitoring of their safety. The risk …

Mesenchymal stem cells (MSCs) have been demonstrated as promising cell sources for
tissue regeneration due to their capability of self-regeneration, differentiation, and …

Over the past few years, mesenchymal stem (or stromal) cells (MSCs) have garnered
enormous interest due to their therapeutic value especially for their multilineage …

Mesenchymal stem/stromal cells (MSCs) are a reservoir for tissue homeostasis and repair
that age during organismal aging. Beside the fundamental in vivo role of MSCs, they have …

Stem cells transplanted to the ischemic myocardium usually encounter massive cell death
within a few days of therapy. Hypoxic preconditioning (HPC) is currently employed as a …

It is well accepted that age is an important contributing factor to poor cartilage repair
following injury, and to the development of osteoarthritis. Cellular senescence, the loss of …